Sante Mernaud Pharmaceuticals Private Limited - Company Profile

It is a fmcg private limited company based in Bangalore, Karnataka, India, established in 2006.
2006 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About Sante Mernaud Pharmaceuticals Private Limited

Sante Mernaud Pharmaceuticals Private Limited, a active private limited company, was established on 26 June 2006 in Bangalore, Karnataka, India. Engaging in personal care & skincare products within the manufacturing sector, it holds CIN: U24239KA2006PTC039813. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.38 Cr.

It upholds a active non-compliant status. Its leadership includes Motilal Heeralal Doddamani (Whole-Time Director), Kalennahalli Siddalingaiah Jagadesha (Director), Amogh S Hiremath (Director). Past directors included Shivabal Ramachandra Khokate, Shashikala Annasaheb Jolle, Padubidre Sakharama Prabhu. It holds ₹1.37 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at No.466 12Th A Cross Peenya 4Th Phase Peenya Industrial Area Peenya, Bangalore, Karnataka, 560058.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239KA2006PTC039813

  • Registration Number

    039813

  • Incorporation Date

    26 June 2006

  • Authorized Capital

    ₹1.50 Cr

  • Paid-Up Capital

    ₹1.38 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 Cr
  • Paid Up Capital ₹ 1.38 Cr
  • Company Age 19 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.37 Cr
  • Revenue Growth **** 20.58%
  • Profit Growth **** 76.46%
  • Ebitda **** 712.91%
  • Net Worth 0.43%
  • Total Assets -7.83%
Company report

Sante Mernaud Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sante Mernaud Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sante Mernaud Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Motilal Heeralal Doddamani Whole-Time Director 01 Mar 2012 Current
Kalennahalli Siddalingaiah Jagadesha Director 10 May 2021 Current
Amogh S Hiremath Director 19 Dec 2020 Current
Shoba Hiremath Director 26 Jun 2006 Current
Shivabasavesh Prabhudevayya Hiremath Director 26 Jun 2006 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 03 Sep 2013 Past
Pramod Abcsdd Director 14 Sep 2012 Past
Pramod Abcsdd Director 04 Sep 2013 Past
Pramod Abcsdd Director 31 Dec 2012 Past
Pramod Abcsdd Director 14 Sep 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sante Mernaud Pharmaceuticals.

Sante Mernaud Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 20.58% increase. The company also saw a substantial improvement in profitability, with a 76.46% increase in profit. The company's net worth moved up by a moderate rise of 0.43%.

Sante Mernaud Pharmaceuticals revenue growth over time
Sante Mernaud Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 20.58%
*******
*******
*******
*******
Revenue from Operations
*******
 65.09%
*******
*******
*******
*******
Total Assets
*******
 -7.83%
*******
*******
*******
*******
Profit or Loss
*******
 76.46%
*******
*******
*******
*******
Net Worth
*******
 0.43%
*******
*******
*******
*******
EBITDA
*******
 712.91%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sante Mernaud Pharmaceuticals?

In 2020, Sante Mernaud Pharmaceuticals had a promoter holding of 73.26% and a public holding of 26.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹13,650,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Canara Bank : 1.37 Cr
Latest Charge Details
Date Lender Amount Status
10 Jul 2007 Canara Bank ₹0.65 M Open
21 Mar 2007 Canara Bank ₹1.30 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Sante Mernaud Pharmaceuticals?

Sante Mernaud Pharmaceuticals has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sante Mernaud Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sante Mernaud Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sante Mernaud Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Sante Mernaud Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Sante Mernaud Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was documented.

  • Director Appointment

    Kalennahalli Siddalingaiah Jagadesha was appointed as a Director was appointed as a Director on 10 May 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.

  • Director Appointment

    The activity Amogh S Hiremath was appointed as a Director was appointed as a Director on 19 Dec 2020 & has been associated with this company since 5 years 3 months . was completed.

  • Charges

    Progress on A charge with Canara Bank of Rs. 1.30 Cr registered on 21 Mar 2007 with Charge ID 10050022 was modified on 08 Dec 2016. was documented.

  • Director Appointment

    Motilal Heeralal Doddamani was appointed as a Whole-time director was appointed as a Whole-time director on 01 Mar 2012 & has been associated with this company since 14 years 28 days . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sante Mernaud Pharmaceuticals Private Limited?

The CIN of Sante Mernaud Pharmaceuticals Private Limited is U24239KA2006PTC039813.

Where is Sante Mernaud Pharmaceuticals Private Limited headquartered?

Sante Mernaud Pharmaceuticals Private Limited is headquartered at No.466 12Th A Cross Peenya 4Th Phase Peenya Industrial Area Peenya, Bangalore, Karnataka, 560058.

When was Sante Mernaud Pharmaceuticals Private Limited incorporated?

Sante Mernaud Pharmaceuticals Private Limited was incorporated on 26 June 2006.

Who are the current directors of Sante Mernaud Pharmaceuticals Private Limited?

The current directors of Sante Mernaud Pharmaceuticals Private Limited are

What is the primary industry of Sante Mernaud Pharmaceuticals Private Limited?

The primary industry of Sante Mernaud Pharmaceuticals Private Limited is Manufacturing.

Is Sante Mernaud Pharmaceuticals Private Limited a listed company?

Sante Mernaud Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Sante Mernaud Pharmaceuticals Private Limited?

The authorized capital of Sante Mernaud Pharmaceuticals Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.38 Cr.

What is the compliance status of Sante Mernaud Pharmaceuticals Private Limited?

The compliance status of Sante Mernaud Pharmaceuticals Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available